Bradrick Named to Spectrum Pharmaceuticals Board of Directors
Oramed Pharmaceuticals completes patient enrolment for Phase 3 ORA-D-013-1 study of ORMD-0801
First Patient Dosed in Phase 2 Clinical Study Evaluating HTD1801 in Type 2 Diabetes Mellitus
Former ViaCyte CEO Paul Laikind Joins Stemson Therapeutics Board of Directors
Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients
Sciwind Biosciences start dosing subjects in phase one XW004 clinical trial